Lightning Round OT: Cerner, MannKind and More

MannKind : “It’s got some FDA hurdles up ahead,” Cramer said. So stay away from MNKD.

Exide Technologies : XIDE could work as a good speculation play, Cramer said.

Cerner : Cramer is bullish on CERN.







Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com